FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

5572511000001101: Naratriptan 2.5mg tablets 4 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22874901000001116 Naratriptan 2.5mg tablets 4 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22875001000001116 Naratriptan 2.5mg tablets 4 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Naratriptan 2.5mg tablets 4 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets 4 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets 4 tablet Is pack of Product containing precisely naratriptan (as naratriptan hydrochloride) 2.5 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets 4 tablet Has active ingredient Naratriptan hydrochloride false Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets 4 tablet Has active ingredient Naratriptan false Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets 4 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets 4 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets 4 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets 4 tablet Has VMP Product containing precisely naratriptan (as naratriptan hydrochloride) 2.5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets 4 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Naratriptan true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets 4 tablet Has specific active ingredient Naratriptan hydrochloride true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets 4 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets 4 tablet Has basis of strength substance Naratriptan true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Naramig 2.5mg tablets (PI) (Dowelhurst Ltd) 4 tablet Is a True Naratriptan 2.5mg tablets 4 tablet Inferred relationship Existential restriction modifier
Naramig 2.5mg tablets (Doncaster Pharmaceuticals Ltd) 4 tablet Is a True Naratriptan 2.5mg tablets 4 tablet Inferred relationship Existential restriction modifier
Naramig 2.5mg tablets (Sigma Pharmaceuticals Plc) 4 tablet Is a True Naratriptan 2.5mg tablets 4 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start